カテゴリ： MarketLine, アメリカ, 企業調査

AbbVie Inc.：企業の戦略・SWOT・財務情報

◆英語タイトル：AbbVie Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C15235
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：67
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

AbbVie Inc. – Strategy, SWOT and Corporate Finance Report
Summary

AbbVie Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

AbbVie Inc. (AbbVie or ‘the company’) is a biopharmaceutical company. The company offers pharmaceutical products that mainly consist of Humira (adalimumab) and products in therapeutic areas of oncology, metabolics/hormone, endocrinology, and virology. It offers products for people of every stage across infant, adolescent, adult and senior. The company also provides patient support programs and partners with biotechs, government organizations, and universities. AbbVie has manufacturing facilities in Ireland, the US, China, Singapore, Germany and in Italy. It also operates R&D centers in Germany, the US and Japan. The company operates in the US, Canada, Mexico, European Union, Japan, Brazil and other countries. The company is headquartered in North Chicago, Illinois, the US.

Scope

- Detailed information on AbbVie Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AbbVie Inc. in the form of a SWOT analysis
- An in-depth view of the business model of AbbVie Inc. including a breakdown and examination of key business segments
- Intelligence on AbbVie Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AbbVie Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of AbbVie Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AbbVie Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on AbbVie Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
AbbVie Inc.: Company Overview
AbbVie Inc.: Overview and Key Facts
AbbVie Inc.: Overview
AbbVie Inc.: Key Facts
AbbVie Inc.: Key Employees
AbbVie Inc.: Key Employee Biographies
AbbVie Inc.: Major Products and Services
AbbVie Inc.: Company History
AbbVie Inc.: Management Statement
AbbVie Inc.: Locations and Subsidiaries
AbbVie Inc.: Key Competitors
AbbVie Inc.: Company Analysis
AbbVie Inc.: Business Description
AbbVie Inc.: SWOT Analysis
AbbVie Inc.: SWOT Overview
AbbVie Inc.: Strengths
AbbVie Inc.: Weaknesses
AbbVie Inc.: Opportunities
AbbVie Inc.: Threats
AbbVie Inc.: Corporate Financial Deals Activity
AbbVie Inc.: Financial Deals Overview
AbbVie Inc.: Targets and Partners
AbbVie Inc.: Top Deals 2015 – 2019YTD*
AbbVie Inc.: Advisors
AbbVie Inc.: Top Legal Advisors
AbbVie Inc.: Top Financial Advisors
AbbVie Inc.: Mergers and Acquisitions
AbbVie Inc.: Corporate Venturing
AbbVie Inc.: Capital Raising
AbbVie Inc.: Partnership
AbbVie Inc.: Recent Developments
AbbVie Inc.: News and Events Summary
AbbVie Inc.: Business Expansion
AbbVie Inc.: Contracts
AbbVie Inc.: Financial Deals
AbbVie Inc.: Market Developments
AbbVie Inc.: Regulatory and Legal Events
AbbVie Inc.: Research & Development
AbbVie Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: AbbVie Inc.: Key Facts
Table 2: AbbVie Inc.: Key Employees
Table 3: AbbVie Inc.: Company History
Table 4: AbbVie Inc.: Locations and Subsidiaries
Table 5: AbbVie Inc.: Key Competitors
Table 6: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: AbbVie Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: AbbVie Inc.: M&A Average Deal Size - Value (US$m)
Table 9: AbbVie Inc.: Targets and Partners
Table 10: AbbVie Inc.: Top Deals 2015 - 2019YTD*
Table 11: AbbVie Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: AbbVie Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: AbbVie Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: AbbVie Inc.: M&A Activity by Geography (2015 - YTD*2019)
Table 15: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 16: AbbVie Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 17: AbbVie Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 18: AbbVie Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Table 19: AbbVie Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 20: AbbVie Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 21: AbbVie Inc.: News and Events Summary
Table 22: AbbVie Inc.: Business Expansion
Table 23: AbbVie Inc.: Contracts
Table 24: AbbVie Inc.: Financial Deals
Table 25: AbbVie Inc.: Market Developments
Table 26: AbbVie Inc.: Regulatory and Legal Events
Table 27: AbbVie Inc.: Research & Development
Table 28: AbbVie Inc.: Strategy and Operations

List of Figures
Figure 1: AbbVie Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: AbbVie Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: AbbVie Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: AbbVie Inc.: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: AbbVie Inc.: M&A Activity by Geography (2015 - YTD*2019)
Figure 6: AbbVie Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 7: AbbVie Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 8: AbbVie Inc.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 9: AbbVie Inc.: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 10: AbbVie Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 11: AbbVie Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)

★海外企業調査レポート[AbbVie Inc.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • GEN energija, d.o.o.：発電所・企業SWOT分析
    GEN energija, d.o.o. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Athenex Inc (ATNX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Athenex Inc (Athenex), formerly Kinex Pharmaceuticals LLC, is a biopharmaceutical company focused on the discovery, development and commercialization novel medicines and cell therapies for the treatment of cancers. The company’s orascovery products candidates include oral formulations of pac …
  • MRC Global Inc (MRC)-石油・ガス分野：企業M&A・提携分析
    Summary MRC Global Inc (MRC) is a provider of pipe, valves and fittings. Its product portfolio include carbon steel pipe, carbon steel fittings and flanges, valve automation, stainless and alloy pipe, stainless and alloy fittings and flanges, industrial products, specialty products, oilfield product …
  • Tokyo Broadcasting System Holdings Inc (9401)：企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings Inc (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Immune Pharmaceuticals Inc (IMNP)：製薬・医療：M&Aディール及び事業提携情報
    Summary Immune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a drug development company that develops novel therapies for immunologic and inflammatory diseases. The company’s pipeline products include Bertilimumab and Nanocyclo. Its Bertilimumab is a human monoclonal antibody designe …
  • Microsoft Corporation (MSFT)-医療機器分野：企業M&A・提携分析
    Summary Microsoft Corporation (Microsoft) is a technology-based company that develops, licenses, and supports software products, services, and devices. The company offers a comprehensive range of operating systems, cross-device productivity applications, server applications, business solution applic …
  • Skandinaviska Enskilda Banken AB：企業のM&A・事業提携・投資動向
    Skandinaviska Enskilda Banken AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Skandinaviska Enskilda Banken AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • TransAlta Corporation：発電所・企業SWOT分析
    TransAlta Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • T&D Holdings, Inc.：企業の戦略・SWOT・財務情報
    T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary T&D Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Physio-Control Inc：医療機器：M&Aディール及び事業提携情報
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Stryker Corp, is a manufacturer of emergency medical response products. The company offers lifepak monitor and defibrillator, lifepak CR plus AED, lifepak express AED, lifenet system, data review software, chest true cprcoaching device, lu …
  • Sany Group Co Ltd：企業の戦略・SWOT・財務情報
    Sany Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sany Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Sysmex Corp (6869)：企業の財務・戦略的SWOT分析
    Sysmex Corp (6869) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • RTL Group S.A. (00007453)：企業の財務・戦略的SWOT分析
    RTL Group S.A. (00007453) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sun Pharma Advanced Research Company Ltd (SPARC)：企業の財務・戦略的SWOT分析
    Summary Sun Pharma Advanced Research Company Ltd (SPARC), a subsidiary of Sun Pharmaceutical Industries Ltd, is a bio pharmaceutical clinical research and development service provider. The company develops active pharmaceutical ingredients, formulations and drug delivery technologies for the treatme …
  • Puncak Niaga Holdings Bhd (PUNCAK)：企業の財務・戦略的SWOT分析
    Puncak Niaga Holdings Bhd (PUNCAK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Electromagnetic Geoservices ASA (EMGS)：企業の財務・戦略的SWOT分析
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …
  • Laboratories Ojer Pharma SL：製薬・医療：M&Aディール及び事業提携情報
    Summary Laboratories Ojer Pharma SL (Ojer Pharma) is a developer of pharmaceutical products in dermatology. The company's products categories include prescription medicine, over the counter OTC, medical devices and cosmetic products. It offers products such as previderm, dermatul nasal, dermatul lip …
  • Klox Technologies Inc-製薬・医療分野：企業M&A・提携分析
    Summary Klox Technologies Inc (Klox Technologies) is a specialty pharmaceutical company, which focuses on the development and commercialization of a proprietary BioPhotonic technology platform. Its pipeline portfolio includes non-invasive wound care treatment solutions, dermatological treatment solu …
  • Mylan N.V.：企業の戦略・SWOT・財務情報
    Mylan N.V. - Strategy, SWOT and Corporate Finance Report Summary Mylan N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Multi-Color Corp (LABL)：企業の財務・戦略的SWOT分析
    Summary Multi-Color Corp (Multi-Color) is a paper and packaging company that develops, manufactures and markets packaging labels. The company offers products such as self adhesive, RFID and NFC, decals and overlays, luminescent, membrane switches, nameplates and signage, foams and gaskets, domed lab …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆